|
|||||
|
|
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors,and SPOP downregulation with ERG-rearranged prostate cancer |
|
| Authors: | Silvia Hernández-Llodrà PhD Laura Segalés MSc Ainara Safont MSc Nuria Juanpere MD Marta Lorenzo Tech BSc Lluís Fumadó MD PhD Alejo Rodríguez-Vida MD PhD Lluís Cecchini MD PhD Joaquim Bellmunt MD PhD Josep Lloreta-Trull MD PhD |
| Affiliation: | 1. Department of Health and Experimental Sciences, Universitat Pompeu Fabra, Barcelona, Spain;2. Department of Health and Experimental Sciences, Universitat Pompeu Fabra, Barcelona, Spain Department of Pathology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain;3. Department of Pathology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain;4. Department of Urology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain;5. Department of Oncology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain;6. IMIM-Hospital del Mar Research Institute, Barcelona, Spain Harvard Medical School, Boston, Massachusetts |
| Abstract: | |
| Keywords: | ERG FOXA1 grade group prostate cancer prostate-specific antigen recurrence SPOP |